About this course

  • Released: 7/29/2014
  • Expires: 7/29/2017

 

LOW CLINICAL DIAGNOSTIC ACCURACY OF EARLY VS ADVANCED PARKINSON DISEASE: CLINICOPATHOLOGIC STUDY

LEARNING OBJECTIVES:

Upon completion of the article by Adler et al, the participant should be able to:

  • Recognize the importance of an accurate clinical diagnosis of Parkinson disease (PD) for clinical care and research
  • Recognize that there is no current clinical diagnostic test or biomarker for PD diagnosis
  • Discuss the findings from this study assessing the diagnostic accuracy of the clinical diagnosis of PD using neuropathologic findings at autopsy as the gold standard

CORE COMPETENCIES:

The article by Adler et al covers the following core competency:

  • Medical Knowledge

 

NEUROPSYCHOLOGICAL CHANGES IN ASYMPTOMATIC PERSONS WITH ALZHEIMER DISEASE NEUROPATHOLOGY

LEARNING OBJECTIVES:

Upon completion of the article by Monsell et al, the participant should be able to:

  • Recognize that neuropathologic and biomarker changes of Alzheimer disease (AD) begin decades before the onset of symptoms
  • Recognize that little is currently known about the subtle cognitive changes that may occur before a person develops noticeable symptoms of AD
  • Discuss the findings from this study assessing the neuropsychological changes in asymptomatic persons with AD neuropathology compared to those without AD neuropathology

CORE COMPETENCIES:

The article by Monsell et al covers the following core competency:

  • Medical Knowledge

 

AUTHOR DISCLOSURES:

Refer to listing above the references in each article.

THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES

ACCREDITATION STATEMENT

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

MISSION STATEMENT/PROGRAM OBJECTIVES

After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.

PARTICIPANTS

This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.

CREDITS

The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.

The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.

DISCLOSURES

Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.

COMMERCIAL SUPPORT

This CME program receives no commercial support.

Content failed to load, please try again later.

ACCME